nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—CYP1A2—Carmustine—lymphatic system cancer	0.134	0.247	CbGbCtD
Clomipramine—CYP2C19—Teniposide—lymphatic system cancer	0.0978	0.18	CbGbCtD
Clomipramine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0552	0.102	CbGbCtD
Clomipramine—CYP3A4—Cytarabine—lymphatic system cancer	0.048	0.0884	CbGbCtD
Clomipramine—CYP3A4—Teniposide—lymphatic system cancer	0.0473	0.087	CbGbCtD
Clomipramine—ALB—Methotrexate—lymphatic system cancer	0.044	0.0809	CbGbCtD
Clomipramine—ABCB1—Vincristine—lymphatic system cancer	0.038	0.0699	CbGbCtD
Clomipramine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0331	0.0609	CbGbCtD
Clomipramine—ABCB1—Methotrexate—lymphatic system cancer	0.023	0.0423	CbGbCtD
Clomipramine—CYP3A4—Vincristine—lymphatic system cancer	0.0228	0.0419	CbGbCtD
Clomipramine—Urine output increased—Methotrexate—lymphatic system cancer	0.000525	0.00115	CcSEcCtD
Clomipramine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000525	0.00115	CcSEcCtD
Clomipramine—Bladder pain—Methotrexate—lymphatic system cancer	0.000525	0.00115	CcSEcCtD
Clomipramine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000523	0.00114	CcSEcCtD
Clomipramine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00052	0.00114	CcSEcCtD
Clomipramine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000517	0.00113	CcSEcCtD
Clomipramine—Confusional state—Bleomycin—lymphatic system cancer	0.000517	0.00113	CcSEcCtD
Clomipramine—Vision blurred—Carmustine—lymphatic system cancer	0.000517	0.00113	CcSEcCtD
Clomipramine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000515	0.00113	CcSEcCtD
Clomipramine—Tremor—Carmustine—lymphatic system cancer	0.000514	0.00112	CcSEcCtD
Clomipramine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000512	0.00112	CcSEcCtD
Clomipramine—Oedema—Bleomycin—lymphatic system cancer	0.000512	0.00112	CcSEcCtD
Clomipramine—Anaemia—Carmustine—lymphatic system cancer	0.000507	0.00111	CcSEcCtD
Clomipramine—Back pain—Vincristine—lymphatic system cancer	0.000506	0.00111	CcSEcCtD
Clomipramine—Vomiting—Teniposide—lymphatic system cancer	0.000506	0.00111	CcSEcCtD
Clomipramine—Agitation—Carmustine—lymphatic system cancer	0.000504	0.0011	CcSEcCtD
Clomipramine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000502	0.0011	CcSEcCtD
Clomipramine—Asthenia—Fludarabine—lymphatic system cancer	0.000501	0.0011	CcSEcCtD
Clomipramine—Rash—Teniposide—lymphatic system cancer	0.000501	0.0011	CcSEcCtD
Clomipramine—Dermatitis—Teniposide—lymphatic system cancer	0.000501	0.0011	CcSEcCtD
Clomipramine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000499	0.00109	CcSEcCtD
Clomipramine—Headache—Teniposide—lymphatic system cancer	0.000498	0.00109	CcSEcCtD
Clomipramine—Pruritus—Fludarabine—lymphatic system cancer	0.000494	0.00108	CcSEcCtD
Clomipramine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000494	0.00108	CcSEcCtD
Clomipramine—Back pain—Mitoxantrone—lymphatic system cancer	0.000493	0.00108	CcSEcCtD
Clomipramine—Leukopenia—Carmustine—lymphatic system cancer	0.000491	0.00107	CcSEcCtD
Clomipramine—Anorexia—Bleomycin—lymphatic system cancer	0.000488	0.00107	CcSEcCtD
Clomipramine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000487	0.00107	CcSEcCtD
Clomipramine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000485	0.00106	CcSEcCtD
Clomipramine—Anaemia—Vincristine—lymphatic system cancer	0.000484	0.00106	CcSEcCtD
Clomipramine—Agitation—Vincristine—lymphatic system cancer	0.000481	0.00105	CcSEcCtD
Clomipramine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00048	0.00105	CcSEcCtD
Clomipramine—Photosensitivity—Methotrexate—lymphatic system cancer	0.00048	0.00105	CcSEcCtD
Clomipramine—Polyuria—Methotrexate—lymphatic system cancer	0.00048	0.00105	CcSEcCtD
Clomipramine—Hypotension—Bleomycin—lymphatic system cancer	0.000479	0.00105	CcSEcCtD
Clomipramine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000478	0.00105	CcSEcCtD
Clomipramine—Convulsion—Carmustine—lymphatic system cancer	0.000475	0.00104	CcSEcCtD
Clomipramine—Hypertension—Carmustine—lymphatic system cancer	0.000473	0.00104	CcSEcCtD
Clomipramine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000473	0.00104	CcSEcCtD
Clomipramine—Nausea—Teniposide—lymphatic system cancer	0.000472	0.00103	CcSEcCtD
Clomipramine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000471	0.00103	CcSEcCtD
Clomipramine—Vertigo—Vincristine—lymphatic system cancer	0.00047	0.00103	CcSEcCtD
Clomipramine—Leukopenia—Vincristine—lymphatic system cancer	0.000468	0.00103	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000467	0.00102	CcSEcCtD
Clomipramine—Chest pain—Carmustine—lymphatic system cancer	0.000467	0.00102	CcSEcCtD
Clomipramine—Myalgia—Carmustine—lymphatic system cancer	0.000467	0.00102	CcSEcCtD
Clomipramine—Anxiety—Carmustine—lymphatic system cancer	0.000465	0.00102	CcSEcCtD
Clomipramine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00046	0.00101	CcSEcCtD
Clomipramine—Malaise—Mitoxantrone—lymphatic system cancer	0.00046	0.00101	CcSEcCtD
Clomipramine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000457	0.001	CcSEcCtD
Clomipramine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000456	0.000999	CcSEcCtD
Clomipramine—Convulsion—Vincristine—lymphatic system cancer	0.000453	0.000992	CcSEcCtD
Clomipramine—Hypertension—Vincristine—lymphatic system cancer	0.000452	0.000989	CcSEcCtD
Clomipramine—Confusional state—Carmustine—lymphatic system cancer	0.000451	0.000987	CcSEcCtD
Clomipramine—Oedema—Carmustine—lymphatic system cancer	0.000447	0.000979	CcSEcCtD
Clomipramine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000445	0.000975	CcSEcCtD
Clomipramine—Myalgia—Vincristine—lymphatic system cancer	0.000445	0.000975	CcSEcCtD
Clomipramine—Cough—Mitoxantrone—lymphatic system cancer	0.000445	0.000973	CcSEcCtD
Clomipramine—Vomiting—Fludarabine—lymphatic system cancer	0.000444	0.000973	CcSEcCtD
Clomipramine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000441	0.000967	CcSEcCtD
Clomipramine—Rash—Fludarabine—lymphatic system cancer	0.000441	0.000965	CcSEcCtD
Clomipramine—Dermatitis—Fludarabine—lymphatic system cancer	0.00044	0.000964	CcSEcCtD
Clomipramine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00044	0.000963	CcSEcCtD
Clomipramine—Pain—Bleomycin—lymphatic system cancer	0.000438	0.000959	CcSEcCtD
Clomipramine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000438	0.000959	CcSEcCtD
Clomipramine—Headache—Fludarabine—lymphatic system cancer	0.000438	0.000959	CcSEcCtD
Clomipramine—Tachycardia—Carmustine—lymphatic system cancer	0.000437	0.000956	CcSEcCtD
Clomipramine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000436	0.000954	CcSEcCtD
Clomipramine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000434	0.00095	CcSEcCtD
Clomipramine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000434	0.00095	CcSEcCtD
Clomipramine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000434	0.00095	CcSEcCtD
Clomipramine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000432	0.000946	CcSEcCtD
Clomipramine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00043	0.000942	CcSEcCtD
Clomipramine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000429	0.000938	CcSEcCtD
Clomipramine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000427	0.000935	CcSEcCtD
Clomipramine—Oedema—Vincristine—lymphatic system cancer	0.000427	0.000935	CcSEcCtD
Clomipramine—Anorexia—Carmustine—lymphatic system cancer	0.000426	0.000933	CcSEcCtD
Clomipramine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000422	0.000925	CcSEcCtD
Clomipramine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000422	0.000923	CcSEcCtD
Clomipramine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000419	0.000918	CcSEcCtD
Clomipramine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000419	0.000917	CcSEcCtD
Clomipramine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000418	0.000915	CcSEcCtD
Clomipramine—Hypotension—Carmustine—lymphatic system cancer	0.000418	0.000915	CcSEcCtD
Clomipramine—Oedema—Mitoxantrone—lymphatic system cancer	0.000416	0.00091	CcSEcCtD
Clomipramine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000416	0.00091	CcSEcCtD
Clomipramine—Nausea—Fludarabine—lymphatic system cancer	0.000415	0.000909	CcSEcCtD
Clomipramine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000413	0.000904	CcSEcCtD
Clomipramine—Shock—Mitoxantrone—lymphatic system cancer	0.000409	0.000896	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000408	0.000892	CcSEcCtD
Clomipramine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000407	0.000891	CcSEcCtD
Clomipramine—Urticaria—Bleomycin—lymphatic system cancer	0.000407	0.000891	CcSEcCtD
Clomipramine—Anorexia—Vincristine—lymphatic system cancer	0.000407	0.000891	CcSEcCtD
Clomipramine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000406	0.000889	CcSEcCtD
Clomipramine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000405	0.000887	CcSEcCtD
Clomipramine—Insomnia—Carmustine—lymphatic system cancer	0.000405	0.000886	CcSEcCtD
Clomipramine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000404	0.000884	CcSEcCtD
Clomipramine—Irritability—Methotrexate—lymphatic system cancer	0.000402	0.000881	CcSEcCtD
Clomipramine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000402	0.00088	CcSEcCtD
Clomipramine—Paraesthesia—Carmustine—lymphatic system cancer	0.000402	0.000879	CcSEcCtD
Clomipramine—Mood swings—Methotrexate—lymphatic system cancer	0.000399	0.000874	CcSEcCtD
Clomipramine—Hypotension—Vincristine—lymphatic system cancer	0.000399	0.000874	CcSEcCtD
Clomipramine—Dyspnoea—Carmustine—lymphatic system cancer	0.000399	0.000873	CcSEcCtD
Clomipramine—Somnolence—Carmustine—lymphatic system cancer	0.000398	0.000871	CcSEcCtD
Clomipramine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000396	0.000868	CcSEcCtD
Clomipramine—Ataxia—Methotrexate—lymphatic system cancer	0.000396	0.000868	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000389	0.000852	CcSEcCtD
Clomipramine—Decreased appetite—Carmustine—lymphatic system cancer	0.000389	0.000851	CcSEcCtD
Clomipramine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000389	0.000851	CcSEcCtD
Clomipramine—Insomnia—Vincristine—lymphatic system cancer	0.000386	0.000846	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000386	0.000845	CcSEcCtD
Clomipramine—Paraesthesia—Vincristine—lymphatic system cancer	0.000383	0.000839	CcSEcCtD
Clomipramine—Pain—Carmustine—lymphatic system cancer	0.000383	0.000837	CcSEcCtD
Clomipramine—Constipation—Carmustine—lymphatic system cancer	0.000383	0.000837	CcSEcCtD
Clomipramine—Breast disorder—Methotrexate—lymphatic system cancer	0.000381	0.000834	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000379	0.000829	CcSEcCtD
Clomipramine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000378	0.000827	CcSEcCtD
Clomipramine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000373	0.000818	CcSEcCtD
Clomipramine—Decreased appetite—Vincristine—lymphatic system cancer	0.000371	0.000813	CcSEcCtD
Clomipramine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000371	0.000812	CcSEcCtD
Clomipramine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00037	0.000809	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000369	0.000807	CcSEcCtD
Clomipramine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000369	0.000807	CcSEcCtD
Clomipramine—Fatigue—Vincristine—lymphatic system cancer	0.000368	0.000806	CcSEcCtD
Clomipramine—Asthenia—Bleomycin—lymphatic system cancer	0.000368	0.000805	CcSEcCtD
Clomipramine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000366	0.000801	CcSEcCtD
Clomipramine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000366	0.000801	CcSEcCtD
Clomipramine—Pain—Vincristine—lymphatic system cancer	0.000365	0.000799	CcSEcCtD
Clomipramine—Constipation—Vincristine—lymphatic system cancer	0.000365	0.000799	CcSEcCtD
Clomipramine—Pruritus—Bleomycin—lymphatic system cancer	0.000363	0.000794	CcSEcCtD
Clomipramine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000362	0.000791	CcSEcCtD
Clomipramine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000361	0.00079	CcSEcCtD
Clomipramine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000359	0.000785	CcSEcCtD
Clomipramine—Constipation—Mitoxantrone—lymphatic system cancer	0.000356	0.000779	CcSEcCtD
Clomipramine—Pain—Mitoxantrone—lymphatic system cancer	0.000356	0.000779	CcSEcCtD
Clomipramine—Body temperature increased—Carmustine—lymphatic system cancer	0.000354	0.000774	CcSEcCtD
Clomipramine—Abdominal pain—Carmustine—lymphatic system cancer	0.000354	0.000774	CcSEcCtD
Clomipramine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000349	0.000764	CcSEcCtD
Clomipramine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000346	0.000758	CcSEcCtD
Clomipramine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000343	0.00075	CcSEcCtD
Clomipramine—Dysuria—Methotrexate—lymphatic system cancer	0.000341	0.000746	CcSEcCtD
Clomipramine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00034	0.000744	CcSEcCtD
Clomipramine—Abdominal pain—Vincristine—lymphatic system cancer	0.000338	0.000739	CcSEcCtD
Clomipramine—Body temperature increased—Vincristine—lymphatic system cancer	0.000338	0.000739	CcSEcCtD
Clomipramine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000336	0.000735	CcSEcCtD
Clomipramine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000333	0.000728	CcSEcCtD
Clomipramine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00033	0.000723	CcSEcCtD
Clomipramine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00033	0.000722	CcSEcCtD
Clomipramine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000329	0.00072	CcSEcCtD
Clomipramine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000329	0.00072	CcSEcCtD
Clomipramine—Pneumonia—Methotrexate—lymphatic system cancer	0.000327	0.000715	CcSEcCtD
Clomipramine—Vomiting—Bleomycin—lymphatic system cancer	0.000326	0.000713	CcSEcCtD
Clomipramine—Drowsiness—Methotrexate—lymphatic system cancer	0.000325	0.000711	CcSEcCtD
Clomipramine—Depression—Methotrexate—lymphatic system cancer	0.000324	0.000709	CcSEcCtD
Clomipramine—Rash—Bleomycin—lymphatic system cancer	0.000323	0.000707	CcSEcCtD
Clomipramine—Dermatitis—Bleomycin—lymphatic system cancer	0.000323	0.000707	CcSEcCtD
Clomipramine—Asthenia—Carmustine—lymphatic system cancer	0.000321	0.000703	CcSEcCtD
Clomipramine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000316	0.000691	CcSEcCtD
Clomipramine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000315	0.000689	CcSEcCtD
Clomipramine—Sweating—Methotrexate—lymphatic system cancer	0.000311	0.000682	CcSEcCtD
Clomipramine—Haematuria—Methotrexate—lymphatic system cancer	0.00031	0.000678	CcSEcCtD
Clomipramine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000307	0.000673	CcSEcCtD
Clomipramine—Epistaxis—Methotrexate—lymphatic system cancer	0.000306	0.000671	CcSEcCtD
Clomipramine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000306	0.000671	CcSEcCtD
Clomipramine—Asthenia—Vincristine—lymphatic system cancer	0.000306	0.000671	CcSEcCtD
Clomipramine—Diarrhoea—Carmustine—lymphatic system cancer	0.000306	0.00067	CcSEcCtD
Clomipramine—Nausea—Bleomycin—lymphatic system cancer	0.000304	0.000666	CcSEcCtD
Clomipramine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000303	0.000664	CcSEcCtD
Clomipramine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000298	0.000653	CcSEcCtD
Clomipramine—Dizziness—Carmustine—lymphatic system cancer	0.000296	0.000648	CcSEcCtD
Clomipramine—Diarrhoea—Vincristine—lymphatic system cancer	0.000292	0.00064	CcSEcCtD
Clomipramine—Hepatitis—Methotrexate—lymphatic system cancer	0.000292	0.000638	CcSEcCtD
Clomipramine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000289	0.000634	CcSEcCtD
Clomipramine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000288	0.000631	CcSEcCtD
Clomipramine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000286	0.000626	CcSEcCtD
Clomipramine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000285	0.000623	CcSEcCtD
Clomipramine—Vomiting—Carmustine—lymphatic system cancer	0.000284	0.000623	CcSEcCtD
Clomipramine—Dizziness—Vincristine—lymphatic system cancer	0.000282	0.000618	CcSEcCtD
Clomipramine—Rash—Carmustine—lymphatic system cancer	0.000282	0.000617	CcSEcCtD
Clomipramine—Dermatitis—Carmustine—lymphatic system cancer	0.000282	0.000617	CcSEcCtD
Clomipramine—Visual impairment—Methotrexate—lymphatic system cancer	0.000281	0.000615	CcSEcCtD
Clomipramine—Headache—Carmustine—lymphatic system cancer	0.00028	0.000613	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—lymphatic system cancer	0.000273	0.000597	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—lymphatic system cancer	0.000272	0.000595	CcSEcCtD
Clomipramine—Vomiting—Vincristine—lymphatic system cancer	0.000272	0.000594	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000271	0.000593	CcSEcCtD
Clomipramine—Rash—Vincristine—lymphatic system cancer	0.000269	0.000589	CcSEcCtD
Clomipramine—Dermatitis—Vincristine—lymphatic system cancer	0.000269	0.000589	CcSEcCtD
Clomipramine—Headache—Vincristine—lymphatic system cancer	0.000268	0.000586	CcSEcCtD
Clomipramine—Nausea—Carmustine—lymphatic system cancer	0.000266	0.000582	CcSEcCtD
Clomipramine—Angiopathy—Methotrexate—lymphatic system cancer	0.000265	0.000579	CcSEcCtD
Clomipramine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000264	0.000579	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000263	0.000577	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000263	0.000575	CcSEcCtD
Clomipramine—Rash—Mitoxantrone—lymphatic system cancer	0.000262	0.000574	CcSEcCtD
Clomipramine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000262	0.000574	CcSEcCtD
Clomipramine—Chills—Methotrexate—lymphatic system cancer	0.000262	0.000573	CcSEcCtD
Clomipramine—Headache—Mitoxantrone—lymphatic system cancer	0.000261	0.00057	CcSEcCtD
Clomipramine—Alopecia—Methotrexate—lymphatic system cancer	0.000258	0.000564	CcSEcCtD
Clomipramine—Mental disorder—Methotrexate—lymphatic system cancer	0.000256	0.000559	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—lymphatic system cancer	0.000254	0.000556	CcSEcCtD
Clomipramine—Nausea—Vincristine—lymphatic system cancer	0.000254	0.000555	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000249	0.000544	CcSEcCtD
Clomipramine—Nausea—Mitoxantrone—lymphatic system cancer	0.000247	0.000541	CcSEcCtD
Clomipramine—Back pain—Methotrexate—lymphatic system cancer	0.000246	0.000538	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—lymphatic system cancer	0.000239	0.000524	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000236	0.000516	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—lymphatic system cancer	0.000235	0.000514	CcSEcCtD
Clomipramine—Malaise—Methotrexate—lymphatic system cancer	0.000229	0.000501	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—lymphatic system cancer	0.000228	0.000499	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—lymphatic system cancer	0.000227	0.000497	CcSEcCtD
Clomipramine—Cough—Methotrexate—lymphatic system cancer	0.000222	0.000485	CcSEcCtD
Clomipramine—Convulsion—Methotrexate—lymphatic system cancer	0.00022	0.000482	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—lymphatic system cancer	0.000216	0.000473	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—lymphatic system cancer	0.000216	0.000473	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—lymphatic system cancer	0.000216	0.000473	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000215	0.00047	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—lymphatic system cancer	0.000214	0.000468	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—lymphatic system cancer	0.000209	0.000457	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000207	0.000454	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000203	0.000445	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000203	0.000444	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—lymphatic system cancer	0.000201	0.000441	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.0002	0.000439	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—lymphatic system cancer	0.000198	0.000432	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—lymphatic system cancer	0.000194	0.000424	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000189	0.000413	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—lymphatic system cancer	0.000187	0.00041	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000186	0.000407	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000185	0.000404	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—lymphatic system cancer	0.000184	0.000403	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000182	0.000399	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00018	0.000394	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000179	0.000392	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—lymphatic system cancer	0.000179	0.000391	CcSEcCtD
Clomipramine—Pain—Methotrexate—lymphatic system cancer	0.000177	0.000388	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000171	0.000374	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000169	0.000371	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—lymphatic system cancer	0.000165	0.00036	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000164	0.000359	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000164	0.000359	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000153	0.000334	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—lymphatic system cancer	0.000149	0.000325	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—lymphatic system cancer	0.000147	0.000321	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000142	0.00031	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—lymphatic system cancer	0.000137	0.0003	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—lymphatic system cancer	0.000132	0.000288	CcSEcCtD
Clomipramine—Rash—Methotrexate—lymphatic system cancer	0.000131	0.000286	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—lymphatic system cancer	0.000131	0.000286	CcSEcCtD
Clomipramine—Headache—Methotrexate—lymphatic system cancer	0.00013	0.000284	CcSEcCtD
Clomipramine—Nausea—Methotrexate—lymphatic system cancer	0.000123	0.000269	CcSEcCtD
